|
|
|
|
|
|
|
Poster: 126
Visits: 65
Title: Nuclear Protein 1 (Nupr1) Expression Contributes To Sorafenib Resistance In Hepatocellular Carcinoma Cells Through Protective Autophagy Activation And P73 Inhibition
Authors: Melchiorre Cervello ,
Centre:
|
|
You must be registered to reply or comment.
|
|
NUCLEAR PROTEIN 1 (NUPR1) EXPRESSION CONTRIBUTES TO SORAFENIB RESISTANCE IN HEPATOCELLULAR CARCINOMA CELLS THROUGH PROTECTIVE AUTOPHAGY ACTIVATION AND P73 INHIBITION
|
|
You must be registered to reply or comment. |
|
|
|
|
|
|
Most viewed poster for this congress |
|
|
Poster: 1
Visits: 241
Title: Pembrolizumab In Combination With Gemcitabine And Cisplatin For The Treatment Of Advanced Biliary Tract Cancer: Phase 3 Keynote-966 Trial In Progress
Authors: Robin Kelley , R.K. KELLEY, A. VOGEL, R.S. FINN, J. FURUSE, J. EDELINE, Z. REN, S.-C. SU, U. MALHOTRA, A.B. SIEGEL, J.W. VALLE
Centre:
|
|
|
|
|
|
|
Poster most viewed in this topic |
|
|
Poster: 103
Visits: 115
Title: Exposure-response analysis for nivolumab ipilimumab combination therapy in patients with advanced hepatocellular carcinoma (CheckMate 040)
Authors: Bruno Sangro ,
Centre:
|
|
|
|